SoundCure(TM) Launches FDA-cleared Serenade(R) Tinnitus Treatment System

SoundCure Inc., a new tinnitus solution provider, announced the launch of the Serenade Tinnitus Treatment System. This marks the formal commercial release of a novel advancement in sound therapy based on the development of S-Tones®, customized treatment sounds developed independently by leading hearing researchers at the University of California, Irvine (UCI).

Serenade is a handheld device that is programmed in the audiologist's office for each individual patient according to his specific condition. Through the device's earphones, the patient listens to therapeutic sounds which are designed to address the underlying neurological cause of tinnitus. Four different treatment sounds are available, anchored by advanced, proprietary S-Tones. Long-term relief can be achieved when used in an on-going sound therapy program.

The American Tinnitus Association provided a grant to UCI to develop the technology.